Tough Times Ahead For Towa As Japanese Generics Giant Slashes 2023 Predictions
Net Profits In Q2 Down Over 70%
Towa has made substantial cuts to its 2023 financial guidance as the difficult conditions of the Japanese generics market begin to take their toll.
